Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension

American Journal of Hypertension

Volumn 18, Issue 11, 2005, Pages 1470-1475

  Nowak, Łukasz ^a   Adamczak, Marcin ^a   Wiȩcek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adiponectin; Hypertension; Insulin resistance; Sympathetic activity

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; RILMENIDINE; TENAXUM;

ADRENERGIC SYSTEM; ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT CONTENT; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC CLEARANCE RATE; PRIORITY JOURNAL; SYMPATHETIC TONE; TIME SERIES ANALYSIS;

ADIPONECTIN; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INSULIN; MALE; MIDDLE AGED; OXAZOLES; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME;

EID: 27644530139     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.05.026     Document Type: Article

References (49)

1. J. Stamler, R. Stamler, J.D. Neaton Blood pressure, systolic and diastolic, and cardiovascular risks US population data Arch Intern Med 153 1993 598 615
2. G. Howard, D.H. O'Leary, D. Zaccaro, S. Haffner, M. Rewers, R. Hamman, J.V. Selby, M.F. Saad, P. Savage, R. Bergman The Insulin Resistance Atherosclerosis Study (IRAS) Investigators Insulin sensitivity and atherosclerosis Circulation 93 1996 1809 1817
3. S.R. Vasan, M.G. Larson, E.P. Leip, J.C. Evans, C.J. O'Donnell, W.B. Kannel, D. Levy Impact of high-normal blood pressure on the risk of cardiovascular disease N Engl J Med 345 2001 1291 1297
4. B.M. Egan, E.L. Greene, T.L. Goodfriend Insulin resistance and cardiovascular disease Am J Hypertens 14 2001 116S 125S
5. A. WieCombining ogonekcek, F. Kokot, J. Chudek, M. Adamczak The adipose tissue-a novel endocrine organ of interest to the nephrologist Nephrol Dial Transplant 17 2002 191 195
6. P.J. Havel Update on adipocyte hormones regulation of energy balance and carbohydrate/lipid metabolism Diabetes 53 Suppl 1 2004 143 151
7. K. Maeda, K. Okubo, T.S.I. Funahashi, Y. Matsuzawa, K. Matsubara cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1) Biochem Biophys Res Commun 221 1996 286 289
8. T. Yokota, K. Oritani, J.T.I. Ishikawa, A. Matsuyama, N. Ouchi, S. Kihara, T. Funahashi, A.J. Tenner, Y. Tomiyama, Y. Matsuzawa Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages Blood 96 2000 1723 1732
9. Y. Arita, S. Kihara, N. Ouchi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, Y. Matsuzawa Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
10. M. Chandran, S.A. Phillips, T. Ciaraldi, R.R. Henry Adiponectin more than just another fat cell hormone? Diabetes Care 26 2003 2442 2450
11. T. Yamauchi, J. Kamon, Y. Ito Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
12. A.E. Civitarese, C.P. Jenkinson, D. Richardson, M. Bajaj, K. Cusi, S. Kashyap, R. Berria, R. Belfort, R.A. DeFronzo, L.J. Mandarino, E. Ravussin Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes Diabetology 47 2004 816 820
13. H. Motoshima, X. Wu, K. Mahadev, B.J. Goldstein Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL Biochem Biophys Res Commun 315 2004 264 271
14. N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, S. Yamashita, T. Funahashi, Y. Matsuzawa Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476
15. N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, K. Hotta, M. Nishida, M. Takahashi, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Funahashi, Y. Matsuzawa Adiponectin and adipocyte-derived plasma protein, inhibits endothelial NFκB signaling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
16. N. Ouchi, S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamota, M. Ishigami, H. Kuriyama, K. Kishida, H. Nishizawa, K. Hotta, M. Muraguchi, Y. Ohmoto, S. Yamashita, T. Funahashi, Y. Matsuzawa Adipocyte-derived plasma protein, adiponectin, suppress lipid accumulation and class A receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
17. Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, M. Kumada, K. Ohashi, N. Sakai, I. Shimomura, H. Kobayashi, N. Terasaka, T. Inaba, T. Funahashi, Y. Matsuzawa Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
18. T. Yamauchi, J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, S. Uchida, Y. Ito, K. Takakuwa, J. Matsui, M. Takata, K. Eto, Y. Terauchi, K. Komeda, M. Tsunoda, K. Murakami, Y. Ohnishi, T. Naitoh, K. Yamamura, Y. Ueyama, P. Froguel, S. Kimura, R. Nagai, T. Kadowaki Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem 278 2003 2461 2468
19. R.B. Ceddia, R. Somwar, A. Maida, X. Fang, G. Bikopulos, G. Sweeney Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells Diabetology 48 2005 132 139
20. Z. Dzielinska, A. Januszewicz, A. Wiecek, M. Demkow, M. Makowiecka-Ciesla, A. Prejbisz, J. Kadziela, R. Mielniczuk, E. Florczak, J. Janas, M. Januszewicz, W. Ruzyllo Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease Thromb Res 110 2003 365 369
21. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa, Y. Matsuzawa Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
22. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, P.A. Tataranni Hypoadiponectinemia in obesity and type 2 diabetes close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935
23. M. Adamczak, A. WieCombining ogonekcek, T. Funahashi, J. Chudek, F. Kokot, Y. Matsuzawa Decreased plasma adiponectin concentration in patients with essential hypertension Am J Hypertens 16 2003 72 75
24. M. Esler The sympathetic system and hypertension Am J Hypertens 13 2000 99 105
25. B.M. Egan Insulin resistance and the sympathetic nervous system Curr Hypertens Rep 5 2003 247 254
26. S. Laurent, M. Safar Rilmenidine a novel approach to first-line treatment of hypertension Am J Hypertens 5 1992 99 105
27. B. Szabo Imidazoline antihypertensive drugs a critical review on their mechanism of action Pharmacol Ther 93 2002 1 35
28. B. Szabo, C. Bock, U. Nordheim, N. Niederhoffer Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine Ann N Y Acad Sci 21 1999 253 264
29. R.A. DeFronzo, J.D. Tobin, R. Andres Glucose clamp technique a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 214 223
30. M. Furuhashi, N. Ura, K. Higashiura, H. Murakami, M. Tanaka, N. Moniwa, D. Yoshida, K. Shimamoto Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension Hypertension 42 2003 76 81
31. C. Bock, N. Niederhoffer, B. Szabo Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine Naunyn Schmiedebergs Arch Pharmacol 359 1999 262 271
32. S.L. Burke, S.C. Malpas, G.A. Head Effect of rilmenidine on cardiovascular responses to stress in the conscious rabbit J Auton Nerv Syst 72 1998 177 186
33. R. Urban, B. Szabo, K. Starke Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304 Eur J Pharmacol 282 1995 29 37
34. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, R. Paschke Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes FEBS Lett 507 2001 142 146
35. G. Bricca, M. Dontewill, A. Molines, J. Feldman, A. Belcourt, P. Bousquet Evidence for existance of a homogenous population of imidazoline receptors in the human brainstem Eur. J. Pharmacol 150 1988 401 402
36. A. Schulz, A. Hasselblatt An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors Naunyn Schmiedebergs Arch Pharmacol 340 1989 321 327
37. S. Efendic, A.M. Efanov, P.O. Berggren, S.V. Zaitsev Two generations of insulinotropic imidazoline compounds Diabetes 51 Suppl 3 2002 448 454
38. J.S. Bogan, H.F. Lodish Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4 J Cell Biol 146 1999 609 620
39. K.C. Huang, C.L. Chen, L.M. Chuang, S.R. Ho, T.Y. Tai, W.S. Yang Plasma adiponectin levels and blood pressures in nondiabetic adolescent females J Clin Endocrinol Metab 88 2003 4130 4134
40. Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, K. Sugimoto, Y. Fu, M. Motone, K. Yamamoto, A. Matsuo, K. Ohashi, S. Kihara, T. Funahashi, H. Rakugi, Y. Matsuzawa, T. Ogihara Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 2004 1 6
41. N. Ouchi, M. Ohishi, S. Kihara, T. Funahashi, T. Nakamura, H. Nagaretani, M. Kumada, K. Ohashi, Y. Okamoto, H. Nishizawa, K. Kishida, N. Maeda, A. Nagasawa, H. Kobayashi, H. Hiraoka, N. Komai, M. Kaibe, H. Rakugi, T. Ogihara, Y. Matsuzawa Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
42. K.C. Tan, A. Xu, W.S. Chow, M.C. Lam, V.H. Ai, S.C. Tam, K.S. Lam Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation J Clin Endocrinol Metab 89 2004 765 769
43. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
44. J.P. McKaigue, D.W. Harron The effects of rilmenidine on tests of autonomic function in humans Clin Pharmacol Ther 52 1992 511 517
45. V. Mitrovic, W. Patyna, J. Huting, M. Schlepper Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension Cardiovasc Drugs Ther 5 1991 967 972
46. F. Sannajust, G.A. Head Involvement of imidazoline-preferring receptors in regulation of sympathetic tone Am J Cardiol 74 1994 7 19
47. M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, S. Matsumoto, N. Ouchi, Y. Arita, Y. Okamoto, I. Shimomura, H. Hiraoka, T. Nakamura, T. Funahashi, Y. Matsuzawa Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
48. M. Daimon, T. Oizumi, T. Saitoh, W. Kameda, A. Hirata, H. Yamaguchi, H. Ohnuma, M. Igarashi, M. Tominaga, T. Kato Funagata study. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study Diabetes Care 26 2003 2015 2020
49. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 14 2004 1730 1737